Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group:: Comparison with the activities of 14 other agents

被引：25

作者：

Betriu, C ^{[1
]}

Gómez, M ^{[1
]}

Palau, ML ^{[1
]}

Sánchez, A ^{[1
]}

Picazo, JJ ^{[1
]}

机构：

[1] Hosp Clin San Carlos, Serv Microbiol Clin, Madrid 28040, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1999年 / 43卷 / 09期

关键词：

D O I：

10.1128/AAC.43.9.2320

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The antimicrobial activities of trovafloxacin, moxifloxacin, sanfetrinem, quinupristin-dalfopristin, and 14 other antimicrobial agents against 218 Bacteroides fragilis group strains were determined. A group of 10 imipenem-resistant strains were also tested. Imipenem, meropenem, and sanfetrinem had the lowest MICs of all of the beta-lactams. Quinupristin-dalfopristin inhibited all of the strains at 2 mu g/ml. Overall, the MICs of trovafloxacin and moxifloxacin for 90% of the strains tested were 1 and 2 mu g/ml, respectively.

引用

页码：2320 / 2322

页数：3

共 20 条

[1] A 5-YEAR MULTICENTER STUDY OF THE SUSCEPTIBILITY OF THE BACTEROIDES-FRAGILIS GROUP ISOLATES TO CEPHALOSPORINS, CEPHAMINS, PENICILLINS, CLINDAMYCIN, AND METRONIDAZOLE IN THE UNITED-STATES
ALDRIDGE, KE
GELFAND, M
RELLER, LB
AYERS, LW
PIERSON, CL
SCHOENKNECHT, F
TILTON, RC
WILKINS, J
HENDERBERG, A
SCHIRO, DD
JOHNSON, M
JANNEY, A
SANDERS, CV
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 18 (04) : 235 - 241
[2] Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes
Aldridge, KE
Ashcraft, DS
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) : 709 - 711
[3] SUSCEPTIBILITY OF 539 GRAM-POSITIVE AND GRAM-NEGATIVE ANAEROBES TO NEW AGENTS, INCLUDING RP59500, BIAPENEM, TROSPECTOMYCIN AND PIPERACILLIN TAZOBACTAM
APPELBAUM, PC
SPANGLER, SK
JACOBS, MR
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (02) : 223 - 231
[4] Interactions of B-Lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral β-lactams
Babini, GS
Yuan, MF
Livermore, DM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) : 1168 - 1175
[5] SUSCEPTIBILITY PATTERNS AND RESISTANCE TO IMIPENEM IN THE BACTEROIDES-FRAGILIS GROUP SPECIES IN JAPAN - A 4-YEAR STUDY
BANDOH, K
UENO, K
WATANABE, K
KATO, N
[J]. CLINICAL INFECTIOUS DISEASES, 1993, 16 : S382 - S386
[6] RESISTANCE OF ANAEROBIC-BACTERIA TO ANTIMICROBIAL AGENTS IN SPAIN
BAQUERO, F
REIG, M
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (11) : 1016 - 1020
[7] In-vitro susceptibilities of species of the Bacteroides fragilis group to newer β-lactam agents
Betriu, C
Sánchez, A
Gómez, M
Palau, ML
Picazo, JJ
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) : 133 - 136
[8] CHANGES IN THE SUSCEPTIBILITY OF BACTEROIDES-FRAGILIS GROUP ORGANISMS TO VARIOUS ANTIMICROBIAL AGENTS 1979-1989
BETRIU, C
CABRONERO, C
GOMEZ, M
PICAZO, JJ
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (04) : 352 - 356
[9] In vitro and in vivo antibacterial activities of GV129606, a new broad-spectrum trinem
DiModugno, E
Broggio, R
Erbetti, I
Lowther, J
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (12) : 2742 - 2748
[10] Dubreuil L, 1996, MED MALADIES INFECT, V26, P196

← 1 2 →